Trial intelligence / Profile preview

GSK2140944 in Uncomplicated Urogenital Gonorrhea

NCT02294682Phase 2Completed

Sponsor
GSK
Start
Apr 2015
Primary completion
Jul 2016
Modality
Small Molecules
Countries
3
01

Overview

A Phase 2 trial of gepotidacin in gonorrhea, sponsored by GSK. Started Apr 2015; status: completed.

02

Drugs

gepotidacin
03

Conditions

gonorrhea

Beyond the preview

Go deeper on NCT02294682.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02294682.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call